Abstract:Objective To determine staging accuracy of double contrast-enhanced ultrasonography (DCUS)after neoadjuvant chemotherapy,and to evaluate effect during neoadjuvant chemotherapy for advanced gastric carcinoma(AGC).Methods A total of 29 patients with AGC diagnosed by endoscopy were examined and staged using ultrasound after taking oral contrast agent and bolus injection of SonoVue (DCUS)pre-and post-neoadjuvant chemotherapy.T-stage accuracy of post-neoadjuvant chemotherapy and pathological T status of postoperative were compared.All of the subjects were divided into two groups according to RECIST(Response Evaluation Criteria in Solid Tumors):chemotherapy benefit group(22cases,including:complete response 0 cases.partial response 14 cases,stable disease 8 cases)and progressive group(7 cases).The findings of DCUS of AGC tissues were assessed by auto-tracking contrast quantification(ACQ)software.The baseline intensity(BI)and peak intensity(PI)of gastric carcinoma tissues were measured automatically,and the enhanced intensity(EI)of gastric carcinoma tissues was calculated manually(EI =PI-BI).The quantitative analysis findings of DCUS of each patient pre-and postneoadjuvant chemotherapy between two groups were compared adopting repeated measures method.Results The overall accuracy of T staging in AGC patients after neoadjuvant chemotherapy were 65.52％ by DCUS,and 0,42.86％and 92.86％respectively for T2 stage,T3 stage and T4 stage.The agreement of this method was weak between T-stage accuracy post-neoadjuvant chemotherapy and pathological T status of postoperative.The Kappa value was 0.33.The difference value of PI and EI between pre-and postneoadjuvant chemotherapy in AGC patients for benefit group was more than that in progressive group.The main effect of BI in AGC tissues between pre-and post-neoadjuvant chemotherapy was no significant difference between two groups(P＞0.05).Conclusions Restaging by DCUS after neoadjuvant chemotherapy in AGC patients was found to be inaccurate.However,the difference value of PI and EI between pre-and post-neoadjuvant chemotherapy in AGC tissues for benefit group was more than that in progressive group.Thus,the value of PI and EI by ICUS may be a useful clinical parameter with which to evaluate the effect during neoadjuvant chemotherapy and guide therapeutic regimen for AGC patients.

Diagnostic value of oral contrast trans-abdominal ultrasonography for gastric cancer: a meta- analysis

Preliminary clinical use of double contrast-enhanced ultrasonography in diagnosis and preoperative staging of gastric cancer

[Comparison of Preoperative T Staging by Oral Contrast Enhanced Ultrasonography and Double Contrast Enhanced Ultrasonography in Advanced Gastric Carcinoma].

[Diagnostic Value of Contrast-Enhanced Ultrasonography in Preoperative T-staging of Gastric Cancer].

Preoperative T Staging of Advanced Gastric Cancer Using Double Contrast-Enhanced Ultrasound.

Comparison of Double Contrast-Enhanced Ultrasonography and Endoscopic Ultrasonography in the Preoperative Tstaging of Gastric Carcinoma

Value of Double Contrast-Enhanced Ultrasonography in the Preoperative TN Staging for Gastric Cancer

Clinical Value of Double Contrast-Enhanced Ultrasonography in the Diagnosis of Gastric Stromal Tumors

The value of double contrast-enhanced ultrasonography in Borrmann classification of advanced gastric carcinoma

Evaluation of the T-restaging and Effect after Neoadjuvant Chemotherapy in Advanced Gastric Carcinoma Using Double Contrast-Enhanced Ultrasonography

Assessment of Liver Metastasis in Patients with GastricCancer Using Contrast-Enhanced Ultrasonography Quantitative Analysis

Initial Screening of Gastric Cancer Using Oral Contrast-Enhanced Trans-Abdominal Ultrasonography in Rural Asymptomatic Individuals.

Prospective Comparison of Oral Contrast-Enhanced Transabdominal Ultrasound Imaging With Contrast-Enhanced Computed Tomography in Pre-operative Tumor Staging of Gastric Cancer

Clinical value of oral contrast-enhanced ultrasonography in diagnosis of gastric tumors

Pilot study of double contrast ultrasonography for differentiation degree of gastric cancer

Evaluation of the Chemotherapy Effect in Advanced Gastric Carcinoma Using Double Contrast-Enhanced Ultrasonography

Application of double contrast-enhanced ultrasonography to access the lymph nodes metastasis of gastric carcinoma

Double Contrast-Enhanced Ultrasonography in Preoperative Borrmann Classification of Advanced Gastric Carcinoma: Comparison with Histopathology

Predicting Lymph Node Status In Patients With Early Gastric Carcinoma Using Double Contrast-Enhanced Ultrasonography

Enhancement Patterns Of Gastric Carcinoma On Contrast-Enhanced Ultrasonography: Relationship With Clinicopathological Features

Double Contrast-Enhanced Ultrasonography Evaluation of Preoperative Lauren Classification of Advanced Gastric Carcinoma